Avenue Therapeutics Stock Forecast

Buy candidate since Nov 13, 2025 Gain 1.32%

The Avenue Therapeutics, Inc. stock price gained 1.32% on the last trading day (Monday, 17th Nov 2025), rising from $0.760 to $0.770. During the last trading day the stock fluctuated 0% from a day low at $0.770 to a day high of $0.770. The price has risen in 6 of the last 10 days and is up by 6.94% over the past 2 weeks. Volume fell on the last day by -251 shares and in total, 1 shares were bought and sold for approximately $0.770 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 25.41% during the next 3 months and, with a 90% probability hold a price between $0.84 and $1.19 at the end of this 3-month period.

ATXI Signals & Forecast

The Avenue Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.763 and $0.747. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, November 04, 2025, and so far it has fallen -16.59%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Avenue Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.710 and $0.668. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Avenue Therapeutics, Inc. finds support just below today's level at $0.710. If this is broken, then the next support from accumulated volume will be at $0.668 and $0.600.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0.542%.

Our recommended stop-loss: $0.729 (-5.40%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (ATXI) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Avenue Therapeutics, Inc. to open at $0.770, and during the day (based on 14 day Average True Range), to move between $0.749 and $0.792, which gives a possible trading interval of +/-$0.0431 (+/-5.75%) up or down from last closing price. If Avenue Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.75% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.80 (3.88%) than the support at $0.710 (7.79%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Avenue Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Avenue Therapeutics, Inc. stock to perform well in the short-term.

Current score: 3.007 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $0.770 ( 0.00000000000001%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk